Nexalin Technology, Inc.: Alumni Capital LP amends Schedule 13G stake filing
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
Alumni Capital LP amended its Schedule 13G filing on Nexalin Technology, Inc., updating its stake disclosure with the SEC under accession number 0001213900-26-121004. The amendment revises the investor's previously reported beneficial ownership position in the medical device maker. Schedule 13G filings are required of investors holding passive stakes above 5% of a company's shares, so the update signals a change in Alumni Capital's position. The specific revised share count and ownership percentage were not detailed in the filing headline. Investors will watch for further 13G or 13D filings to gauge whether Alumni Capital is accumulating or trimming its stake.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Alumni Capital LP, Nexalin Technology, Inc.